Inventor · disambiguated record
Bret Sellman
Also filed as: SELLMAN BRET · SELLMAN BRET R · SELLMAN BRET RICHARD
18 granted patents·12 pending applications·95 citations·filing 2001–2025
93Inventor score
Top patents by PatentIndex Score
30 records- 0191US10730934B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2018·Granted Aug 4, 2020·6 cites·21 claims
- 0290US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0389US11059884B2Antibodies directed against Staphylococcus aureus leukotoxinsMEDIMMUNE LLC·Filed 2019·Granted Jul 13, 2021·4 cites·28 claims
- 0489US10844114B2Anti-Pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Nov 24, 2020·3 cites·21 claims
- 0589US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0687US11578119B2Antibodies directed against Staphylococcus aureus leukotoxinsMEDIMMUNE LLC·Filed 2021·Granted Feb 14, 2023·1 cites·20 claims
- 0787US11155606B2Antibody directed against S. aureus clumping factor a (ClfA)MEDIMMUNE LLC·Filed 2019·Granted Oct 26, 2021·3 cites·18 claims
- 0887US10370436B2Anti-pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Aug 6, 2019·5 cites·5 claims
- 0987US9527905B2Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of useSELLMAN BRET·Filed 2012·Granted Dec 27, 2016·23 cites·9 claims
- 1086US7037503B2Compounds and methods for the treatment and prevention of bacterial infectionHARVARD COLLEGE·Filed 2001·Granted May 2, 2006·27 cites·10 claims
- 1185US11168133B2Combinations of anti-Staphylococcus aureus antibodiesMEDIMMUNE LLC·Filed 2019·Granted Nov 9, 2021·3 cites·22 claims
- 1284US11447543B2Antibodies to S. aureus surface determinantsMEDIMMUNE LLC·Filed 2020·Granted Sep 20, 2022·1 cites·12 claims
- 1381US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 1479US2024352098A1ANTIBODY DIRECTED AGAINST S. AUREUS CLUMPING FACTOR A (ClfA)MEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 1578US11168132B2Treatment of polybacterial infectionsMEDIMMUNE LLC·Filed 2015·Granted Nov 9, 2021·4 cites·10 claims
- 1677US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 1773US11970527B2Antibody directed against S. aureus clumping factor A (ClfA)MEDIMMUNE LLC·Filed 2021·Granted Apr 30, 2024·0 cites·15 claims
- 1872US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1969US2021130442A1Anti-pseudomonas psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 2063US2022089699A1Combinations of anti-staphylococcus aureus antibodiesMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 2162US2025382356A1Anti-pcrv and psl bispecific antibodies for treatment of bronchiectasisASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2256US2015196629A1Immunogenic Compositions Of Staphylococcus Epidermidis Polypeptide AntigensWYETH LLC·Filed 2015·Application pending·0 cites
- 2356US2025304663A1Decreasing staphylococcus aureus infections in colonized patientsMEDIMMUNE LLC·Filed 2025·Application pending·0 cites
- 2454US2013209501A1Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide AntigensWYETH LLC·Filed 2013·Application pending·0 cites
- 2553US12264194B2Decreasing Staphylococcus aureus infections in colonized patientsMEDIMMUNE LLC·Filed 2020·Granted Apr 1, 2025·0 cites·20 claims
- 2648US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2747US8445000B2Immunogenic compositions of Staphylococcus epidermidis polypeptide antigensSELLMAN BRET RICHARD·Filed 2005·Granted May 21, 2013·0 cites·21 claims
- 2845US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 2936US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 3028US2019077851A1Methods of using anti-alpha toxin antibodyFRANCOIS BRUNO·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →